Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.
Also called NCT02437084
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 115 participants
- Sponsor
- Registry
-
NCT02437084
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02437084. Allocation not applicable; no masking; primary purpose treatment. Start 2015-05 (actual); primary completion 2020-02 (actual). Results posted on 2021-04-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling
- Condition
- Hyperlipidemia
- Condition
- Insulin Resistance
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- Stanford University
- Collaborator
- Doris Duke Charitable Foundation
Record details
- Record id
cardio:ct-nct02437084- Content hash
a3d585eb30a3bf5b0d1dec4787793d91751b2ae663d83de2c890876081ad944b